Rheumatoid arthritis is linked to Proteus - The evidence

Clinical Rheumatology

Volumn 26, Issue 7, 2007, Pages 1036-1043

  Rashid, Taha ^a   Ebringer, Alan ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Proteus; Rheumatoidarthritis

Indexed keywords

ANTIBIOTIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ANTIBODY;

CLINICAL FEATURE; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; DIET; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HEREDITY; HUMAN; LONGITUDINAL STUDY; MYCOBACTERIUM; MYCOPLASMA; NONHUMAN; PARVOVIRUS; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; REVIEW; RHEUMATOID ARTHRITIS; RUBELLA VIRUS; URINARY TRACT; VIRUS INFECTION;

ANTIBODIES, BACTERIAL; ARTHRITIS, REACTIVE; ARTHRITIS, RHEUMATOID; HUMANS; PROTEUS INFECTIONS; PROTEUS MIRABILIS;

EID: 34249904650     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0491-z     Document Type: Review

References (76)

1. Cooper NJ (2000) Economic burden of rheumatoid arthritis a systematic review. Rheumatology 39:28-33
2. Sacks JJ, Helmick CG, Langmaid G (2004) Deaths from arthritis and other rheumatic conditions, United States, 1979-1998. J Rheumatol 31:1823-1828
3. Turesson C, Mattesson EL (2006) Genetics of rheumatoid arthritis. Mayo Clin Proc 81:94-101
4. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43:30-37
5. Stastny P (1976) Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 57:1148-1157
6. Watanabe Y, Tokunaga K, Matsuki K, Takeuchi F, Matsuta K, Maeda H et al (1989) Putative amino acid sequence of HLA-DRβ chain contributing to rheumatoid arthritis susceptibility. J Exp Med 169:2263-2268
7. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213
8. Wallin J, Hillert J, Olerup O, Carlsson B, Strom H (1991) Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes. Arthritis Rheum 34:1416-1424
9. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH (2002) Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31:355-360
10. Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA (2004) Impact of shared epitope genotype and ethnicity on erosive disease: A meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 50:400-412
11. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A et al (1993) Twin concordance rates for rheumatoid arthritis: Results from a nation-wide study. Br J Rheumatol 32:903-907
12. Svendsen AJ, Holm NV, Kyvik K, Petersen PH, Junker P (2002) Relative importance of genetic effects in rheumatoid arthritis: Historical cohort study of Danish nationwide twin population. Br Med J 324:264-266
13. Sawada S, Takei M (2005) Epstein-Barr virus etiology in rheumatoid synovitis. Autoimmun Rev 4:106-110
14. Rickinson AB, Kieff E (1996) Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM et al (eds) Fields virology. Lippincott-Raven, Philadelphia, pp 2397-2446
15. Callan MF (2004) Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr Opin Rheumatol 16:399-405
16. Berthelot JM, Saulquin X, Coste-Burel M, Peyrat MA, Echasserieau K, Bonneville M et al (2003) Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: A 15 month follow-up pilot study. J Rheumatol 30:1673-1679
17. Fox RI, Chilton T, Rhodes G, Vaughan JH (1986) Lack of reactivity of rheumatoid arthritis synovial membrane DNA with cloned Epstein-Barr virus DNA probes. J Immunol 137:498-501
18. Niedobitek G, Lisner R, Swoboda B, Rooney N, Fassbender HG, Kirchner T et al (2000) Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 43:151-154
19. Murai C, Munakata Y, Takahashi Y, Ishii T, Shibata S, Muryoi T et al (1999) Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis 58:130-132
20. Takasawa N, Munakata Y, Ishii KK, Takahashi Y, Takahashi M, Fu Y et al (2004) Human parvovirus B19 transgenic mice become susceptible to polyarthritis. J Immunol 173:4675-4683
21. Nikkari S, Luukkainen R, Mottonen T, Meurman O, Hannonen P, Skurnik M et al (1994) Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis 53:106-111
22. Meyer O (2003) Parvovirus B19 and autoimmune diseases. Joint Bone Spine 70:6-11
23. Bosma TJ, Etherington J, O'Shea S, Corbett K, Cottam F, Holt L et al (1998) Rubella virus and chronic joint disease: Is there an association? J Clin Microbiol 36:3524-3526
24. Zhang D, Nikkari S, Vainionpaa R, Luukkainen R, Yli-Kerttula U, Toivanen P (1997) Detection of rubella, mumps, and measles virus genomic RNA in cells from synovial fluid and peripheral blood in early rheumatoid arthritis. J Rheumatol 24:1260-1265
25. Mehraein Y, Lennerz C, Ehlhardt S, Remberger K, Ojak A, Zang KD (2004) Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol 17:781-789
26. Holoshitz J, Klajman A, Drucker I, Lapidot Z, Yaretzky A, Frenkel A et al (1986) T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet 2:305-309
27. Horowitz S, Evinson B, Borer A, Horowitz J (2000) Mycoplasma fermentans in rheumatoid arthritis and other inflammatory arthritides. J Rheumatol 27:2747-2753
28. Auger I, Escola JM, Gorvel JP, Roudier J (1996) HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins. Nat Med 2:306-310
29. Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Coster L et al (2005) Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 52:1986-1992
30. Van Eden W, Thole JE, van der Zee R, Noordzij A, van Embden JD, Hensen EJ et al (1988) Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331:171-173
31. Gaston JS, Life PF, Bailey LC, Bacon PA (1989) In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J Immunol 143:2494-2500
32. Res PC, Telgt D, van Laar JM, Pool MO, Breedveld FC, de Vries RR (1990) High antigen reactivity in mononuclear cells from sites of chronic inflammation. Lancet 336:1406-1408
33. Van der Heijden IM, Wilbrink B, Schouls LM, van Embden JD, Breedveld FC, Tak PP (1999) Detection of mycobacteria in joint samples from patients with arthritis using a genus-specific polymerase chain reaction and sequence analysis. Rheumatology 38:547-553
34. Haier J, Nasralla M, Franco AR, Nicolson GL (1999) Detection of mycoplasma infections in blood of patients with rheumatoid arthritis. Rheumatology 38:504-509
35. Schaeverbeke T, Gilroy CB, Bebear C, Dehais J, Taylor-Robinson D (1996) Mycoplasma fermentans, but not M. penetrans, detected by PCR assays in synovium from patients with rheumatoid arthritis and other rheumatic disorders. J Clin Pathol 49:824-828
36. Hoffman RW, O'Sullivan FX, Schafermeyer KR, Moore TL, Roussell D, Watson-McKown R et al (1997) Mycoplasma infection and rheumatoid arthritis: Analysis of their relationship using immunoblotting and an ultrasensitive polymerase chain reaction detection method. Arthritis Rheum 40:1219-1228
37. Albani S, Tuckwell JE, Esparza L, Carson DA, Roudier J (1992) The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule. J Clin Invest 89:327-331
38. Handley HH, Yu J, Yu DT, Singh B, Gupta RS, Vaughan JH (1996) Autoantibodies to human heat shock protein (hsp) 60 may be induced by Escherichia coli groEL. Clin Exp Immunol 103:429-435
39. Gerard HC, Wang Z, Wang GF, El-Gabalawy H, Goldbach-Mansky R, Li Y et al (2001) Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum 44:1689-1697
40. Ebringer A, Ptaszynska T, Corbett M, Wilson C, Macafee Y, Avakian H et al (1985) Antibodies to Proteus in rheumatoid arthritis. Lancet ii:305-307
41. Khalafpour S, Ebringer A (1987) Cross-reactivity between HLA-DR4 and Proteus mirabilis. Period Biol (Zagreb) 89(Suppl 1):203
42. Ebringer A, Cunningham P, Ahmadi K, Wrigglesworth J, Hosseini R, Wilson C (1992) Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and Proteus/Serratia membrane haemolysins. Ann Rheum Dis 51:1245-1246
43. Wilson C, Ebringer A, Ahmadi K, Wrigglesworth J, Tiwana H, Fielder M et al (1995) Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 54:216-220
44. Tiwana H, Wilson C, Alvarez A, Abuknesha R, Bansal S, Ebringer A (1999) Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun 67:2769-2775
45. Senior BW, Anderson GA, Morley KD, Kerr MA (1999) Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 38:99-106
46. Wilson C, Rashid T, Tiwana H, Beyan H, Hughes L, Bansal S et al (2003) Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 30:972-978
47. Ebringer A, Rashid T, Wilson C (2003) Rheumatoid arthritis: Proposal for the use of anti-microbial therapy in early cases. Scand J Rheumatol 32:2-11
48. Ebringer A, Wilson C, Ahmadi K, Corbett M, Rashid T, Shipley M (1993) Rheumatoid arthritis as a reactive arthritis to Proteus infection: Prospects for therapy. In: Machtey I (ed) Progress in rheumatology, sixth international seminar on the treatment of rheumatic diseases, vol. 5, pp 77-83
49. Wilson C, Thakore D, Isenberg D, Ebringer A (1997) Correlation between anti- Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int 16:187-189
50. Senior BW (1979) The special affinity of particular types of Proteus mirabilis for the urinary tract. J Med Microbiol 12:1-8
51. Ronald AR, Nicolle LE (2001) Infections of the upper urinary tract. In: Schlier RW (ed) Diseases of the kidney and urinary tract. Williams & Wilkins, Philadelphia, pp 941-969
52. Lawson AA, Maclean N (1966) Renal disease and drug therapy in rheumatoid arthritis. Ann Rheum Dis 25:441-449
53. Tishler M, Caspi D, Aimog Y, Segal R, Yaron M (1992) Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjogren's syndrome. Ann Rheum Dis 51:601-606
54. Vandenbroucke JP, Kaaks R, Valkenburg HA, Boersma JW, Cats A, Festen JJ et al (1987) Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis Rheum 30:810-813
55. Wanchu A, Deodhar SD, Sharma M, Gupta V, Bambery P, Sud A (1997) Elevated levels of anti- Proteus antibodies in patients with active rheumatoid arthritis. Indian J Med Res 105:39-42
56. Rashid T, Darlington G, Kjeldsen-Kragh J, Forre O, Collado A, Ebringer A (1999) Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis. Clin Rheumatol 18:190-195
57. Chen T, Rimpilainen M, Luukkainen R, Mottonen T, Yli-Jama T, Jalava J et al (2003) Bacterial components in the synovial tissue of patients with advanced rheumatoid arthritis or osteoarthritis: Analysis with gas chromatography-mass spectrometry and pan-bacterial polymerase chain reaction. Arthritis Rheum 49:328-334
58. Hara Y, Kaneko T, Yoshimura A, Kato I (1996) Serum rheumatoid factor induced by intraperitoneal administration of periodontopathic bacterial lipopolysaccharide in mice. J Periodontal Res 31:502-507
59. Posnett DN, Edinger J (1997) When do microbes stimulate rheumatoid factor? J Exp Med 185:1721-1723
60. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
61. Maddison PJ, Huey P (2004) Serological profile. In: Isenberg DA, Maddison PJ, Woo P, Glass DN, Breedveld FC (eds) Oxford textbook of rheumatology. Oxford University Press, Oxford, pp 491-499
62. Rashid T, Ebringer A, Wilson C, Bansal S, Paimela L, Binder A (2006) The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis. J Clin Rheumatol 12:11-16
63. Roberts LJ, Cleland LG, Thomas R, Proudman SM (2006) Early combination disease modifying antirheumatic drug treatment for rheumatoid arthritis. Med J Aust 184:122-125
64. Van der Heijde D, Klaresdog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J et al (2006) Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis. Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 54:1063-1074
65. Merkesdal S, Ruof J, Mittendorf T, Zeidler H (2004) Cost-effectiveness of TNF-alpha-blocking agents in the treatment of rheumatoid arthritis. Expert Opin Pharmacother 5:1881-1886
66. Fleischmann RM, Iqbal I, Stern RL (2004) Considerations with the use of biological therapy in the treatment of rheumatoid arthritis. Expert Opin Drug Saf 3:391-403
67. Khalafpour S, Ebringer A, Abuljadayel I, Corbett M (1988) Antibodies to Klebsiella and Proteus microorganisms in ankylosing spondylitis and rheumatoid arthritis patients measured by ELISA. Br J Rheumatol 27(Suppl II):86-89
68. Deighton CM, Gray SW, Biant AJ, Walker DJ (1992) Specificity of the Proteus antibody response in rheumatoid arthritis. Ann Rheum Dis 51:1206-1207
69. Subair H, Tiwana H, Fielder M, Binder A, Cunningham K, Ebringer A et al (1995) Elevation in anti- Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 22:1825-1828
70. Fielder M, Tiwana H, Youinou P, Le Goff P, Deonarian R, Wilson C et al (1995) The specificity of the anti- Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest. Rheumatol Int 15:79-82
71. Tiwana H, Wilson C, Cunningham P, Binder A, Ebringer A (1996) Antibodies to four gram-negative bacteria in rheumatoid arthritis which share sequences with the rheumatoid arthritis susceptibility motif. Br J Rheumatol 35:592-594
72. Tiwana H, Wilson C, Walmsley RS, Wakefield AJ, Smith MS, Cox NL et al (1997) Antibody response to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatol Int 17:11-16
73. Tani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C et al (1997) Antibodies to Klebsiella, Proteus and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 24:109-114
74. Blankenberg-Sprenkels SHD, Fielder M, Feldkamp TEW, Tiwana H, Wilson C, Ebringer A (1998) Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol 25:743-747
75. Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS (2005) Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology 44:1433-1441
76. Rashid T, Leirisalo-Repo M, Tani Y, Hukuda S, Kobayashi S, Wilson C et al (2004) Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis. Clin Rheumatol 23:134-141